Synaptigen

What Synaptigen is actually building

Synaptigen is a cognitive support supplement targeting adults 45 and older, built around three ingredients: magnesium L-threonate, lion’s mane mushroom extract, and phosphatidylserine. It is sold through ClickBank at a $49–69/month price point depending on bundle size.

This is where the review diverges meaningfully from every other product we have covered in this category.

Synaptigen’s three ingredients are not marketing choices dressed in scientific language. They are compounds with published human RCTs, identifiable mechanisms, specific dose thresholds, and peer-reviewed replication — the actual vocabulary of an evidence-based formulation. The mechanism they collectively address — supporting synaptic density, neurotrophin synthesis, and neuronal membrane integrity in the aging brain — is coherent, not assembled from trending ingredient lists.

That is not a trivial observation in a category where the typical formulation approach is to identify a vague mechanism (“mitochondrial support,” “neural wire regeneration,” “brown fat activation”), find a cluster of botanicals with preclinical data tangentially related to it, and blend them at sub-clinical doses behind a proprietary label.

Synaptigen did not do that. Whether its actual doses match its ingredient evidence base is the entire remaining question — and it is a real question, because the doses are not fully disclosed.

The label — what’s actually in the capsule

Per the label and available Supplement Facts information reviewed April 2026:

Ingredient	Clinical benchmark dose	Dose in Synaptigen
Magnesium L-threonate (as Magtein or equivalent)	~2,000 mg/day (delivering ~144 mg elemental Mg)	Not individually disclosed
Lion’s mane mushroom extract (Hericium erinaceus)	≥1,000 mg/day fruiting body or equivalent standardized extract	Not individually disclosed
Phosphatidylserine (soy- or sunflower-derived)	300 mg/day	Not individually disclosed

The total capsule count per serving and per bottle is disclosed. The individual ingredient amounts are not displayed on the public sales page. This matters more here than it does for a gimmick formula — because the clinical evidence for all three ingredients is dose-dependent, and the difference between a therapeutic and inert dose is not marginal.

Magnesium L-threonate at 500 mg/day is not the same product as at 2,000 mg/day. Lion’s mane at 200 mg raw powder is not the same product as 1,000 mg standardized hericenone-containing extract. Phosphatidylserine at 100 mg/day does not replicate the Jorissen et al. 300 mg trial. The formula either meets these thresholds or it does not — and without a published Supplement Facts panel, we cannot determine which.

Ingredient-by-ingredient evidence review

Magnesium L-threonate

The development story of Mg L-threonate is unusually documented for a supplement ingredient. It was synthesized by a team at MIT (Liu G et al., 2010, working under Guosong Liu) to address the specific problem of magnesium’s poor blood-brain barrier penetration. The seminal Slutsky et al. (2010, Neuron 65:165–177) paper demonstrated in rats that oral Mg L-threonate, unlike other magnesium forms, elevated CSF magnesium and produced measurable increases in synaptic density and plasticity-related proteins in hippocampal neurons.

The human evidence followed: Mao et al. (2016, J Alzheimers Dis 49:971–990) conducted a double-blind, placebo-controlled trial in 44 adults aged 50–70 with self-reported cognitive complaints. Participants receiving 1.5–2 g/day Mg L-threonate for 12 weeks showed significant improvement on a composite measure of global cognitive ability and on tests of executive function and working memory. The effect size was modest but statistically robust, and the result has been at least partially replicated in subsequent industry-sponsored trials.

Limitations to note: the Mao et al. trial was small (44 participants), and the primary authors have financial relationships with the ingredient manufacturer (Magceutics). Independent replication at scale has not yet been published. These are the same caveats that apply to most early-stage evidence in the cognitive supplement space — but the mechanism is specifically plausible and the data, while preliminary, are real.

Clinical dose: ~2 g/day (delivering approximately 144 mg elemental magnesium). This is the dose that must appear on Synaptigen’s label for the evidence to apply.

Lion’s mane mushroom (Hericium erinaceus)

Lion’s mane is the most biologically interesting ingredient in the Synaptigen formula and also the one with the most nuance attached to it.

The mechanism: hericenones (found in the fruiting body cap) and erinacines (found in the mycelium) both stimulate NGF synthesis via distinct pathways. NGF (nerve growth factor) is a neurotrophin essential for the maintenance of cholinergic neurons in the basal forebrain — the same population that degrades in Alzheimer’s disease and normal cognitive aging. No other dietary ingredient has a comparably documented mechanism for upregulating NGF in humans.

The evidence:

• Mori K et al. (2009, Phytother Res 23:367–372): 30 adults with mild cognitive impairment, 3 g/day standardized lion’s mane powder for 16 weeks. Significant improvement on Revised Hasegawa Dementia Scale vs. placebo. Effect reversed four weeks post-discontinuation.
• Docherty S et al. (2023, J Med Food 26:568–576): 41 healthy young adults, 1.8 g/day for 28 days. Improved speed of memory acquisition on computerized tasks.
• Saitsu Y et al. (2019, Biomed Res 40:125–131): 31 adults aged 50–80, 3.2 g/day standardized extract for 12 weeks. Significant improvements in mini-mental state examination subscores.

The consistent theme: doses of 1.8–3.2 g/day, 12–16 week durations, small samples. The evidence is promising and mechanistically grounded. It is not yet at the level of a large independent RCT — which is the honest description of the lion’s mane field in April 2026.

The formulation nuance that matters: the distinction between whole fruiting body powder and standardized extract for hericenone/erinacine content is not cosmetic. A product containing 1 g of non-standardized mycelium rice powder is not the same as 1 g of standardized fruiting body extract with documented hericenone content. Synaptigen’s label should specify standardization. Whether it does is part of the information that requires direct vendor verification.

Clinical dose: ≥1 g/day of standardized extract (fruiting body, documented hericenone content) or ≥3 g/day of whole dried mushroom powder. Synaptigen needs to be transparent about which it is using.

Phosphatidylserine (PS)

PS is the most established ingredient in the Synaptigen formula by both evidence volume and regulatory recognition. It is a phospholipid concentrated in neuronal synaptic membranes, where it facilitates signal transduction and membrane fluidity. As neurons age, PS content in synaptic membranes declines, which correlates with reductions in neurotransmitter release and receptor sensitivity.

Key human evidence:

• Crook TH et al. (1991, Neurology 41:644–649): 149 older adults with memory complaints, 300 mg/day bovine PS for 12 weeks. Significant improvement on multiple cognitive measures.
• Jorissen BL et al. (2001, Nutritional Neuroscience 4:121–134): 120 adults with age-associated memory impairment, 300 mg/day soy-derived PS for 12 weeks. Improvement in delayed recall and face-name associations.
• Engel RR et al. (meta-analysis): pooled analysis across multiple trials confirmed memory and executive function effects at 200–400 mg/day in older adults with memory decline.

The FDA’s qualified health claim for PS (2003, revised 2004): “Very limited and preliminary scientific research suggests that phosphatidylserine may reduce the risk of cognitive dysfunction in the elderly. FDA concludes that there is little scientific evidence supporting this claim.” This language reflects the FDA’s high bar for health claims, not a dismissal of the evidence — the qualified claim acknowledges both the signal and its preliminary status.

Clinical dose: 300 mg/day. This is a hard threshold in the Synaptigen evaluation — below 300 mg, the Jorissen et al. and Crook et al. data do not directly apply.

The math: cost per clinical dose

This comparison is more favorable to Synaptigen than it is to any other product we have reviewed in this category — and still argues against the bundle pricing.

Product	Dose	Monthly cost
Synaptigen (6-bottle bundle)	Undisclosed	$49/month
Synaptigen (single bottle)	Undisclosed	$69/month
Magtein Mg L-threonate 2,000 mg/day	2g elemental-equivalent	~$28/month
Real Mushrooms Lion’s Mane 1g/day	1g fruiting body, standardized	~$18/month
NOW Phosphatidylserine 300 mg/day	300mg soy-derived	~$22/month
Commodity stack total	All doses disclosed, all standardized	~$68/month

At the 6-bottle Synaptigen price, the product is comparable in cost to a commodity stack delivering all three ingredients at documented clinical doses. At single-bottle pricing ($69), it is slightly more expensive than building the stack yourself. The convenience argument — three compounds in one capsule — is real. But it only holds if Synaptigen’s doses match the clinical benchmarks. If the doses are sub-clinical, the convenience is worthless.

This is an unusual finding in this category: Synaptigen is priced in a range where it could be competitive with a commodity stack, if — only if — the doses are right. That conditional changes the entire evaluation.

Marketing teardown

The Synaptigen funnel, reviewed April 19, 2026, is markedly more restrained than the Quietum Plus, ZenCortex, Puravive, and Mitolyn funnels we reviewed in the same cycle. Specific observations:

• The “origin story” narrative is present but abbreviated — a “neuroscientist” figure is referenced but not named. This is still a red flag; a real formulator would be willing to attach their name to the product.
• The mechanism claims stay closer to the published literature than competitors: “support synaptic plasticity,” “promote NGF synthesis,” “nourish neuronal membranes.” These are fair descriptions of what the ingredients do in the published research. The funnel does not claim to reverse Alzheimer’s disease or restore the cognition of a 25-year-old — a meaningful restraint relative to category norms.
• Countdown timer: present, resets on reload. This is now a universal finding across every product in this category and should be treated as a baseline deceptive pattern regardless of the product’s other merits.
• Testimonials: three present, photographed individuals, at least one of whom does not reverse-image-search to a stock library. This is slightly better than the other products reviewed this cycle.
• The 6-bottle bundle anchor and the $79/$59/$49 pricing ladder are present and follow the category standard.

The funnel is less egregious than its category peers. It is not clean. The unnamed neuroscientist, the countdown timer, and the absence of a published Supplement Facts panel with individual doses are all patterns that should give a careful buyer pause — even when the underlying formulation is genuinely more interesting than the competition.

What we’d want to see before revising this verdict

This is the first product in our ClickBank review series where the path to a higher rating is specific and achievable rather than “conduct a clinical trial that will never happen.”

To move from Cautious (5.8) to Conditional (7.0+):

1. Publish a full Supplement Facts panel with individual ingredient doses per serving
2. Confirm Mg L-threonate dose is ≥2 g/day (or provide elemental magnesium mg and disclose the salt stoichiometry)
3. Confirm lion’s mane is fruiting body-sourced and standardized for hericenone content ≥1 g/day extract equivalent
4. Confirm phosphatidylserine is ≥300 mg/day, soy- or sunflower-derived
5. Provide a current certificate of analysis from a third-party laboratory

To move from Conditional to Recommended (8.0+):

6. Third-party certification (NSF, USP, or Informed Sport)
7. An independent (non-industry-funded) RCT on the finished formulation at the labeled dose

None of this requires new science. It requires transparency about existing formulation decisions that the manufacturer has already made. If the doses are adequate, disclosure costs nothing. If the doses are not adequate, that is the information consumers need.

Bottom line

Synaptigen is the most scientifically coherent supplement we have reviewed in the ClickBank cognitive and specialty-health category. Its three ingredients have real human RCTs, identifiable doses, plausible shared mechanisms, and a coherent target population. The formulation shows genuine literacy about why magnesium L-threonate and not magnesium oxide, why lion’s mane and not generic “mushroom blend,” why phosphatidylserine and not generic “brain health.”

It is also a ClickBank supplement with an unnamed formulator, a fake countdown timer, and no publicly disclosed individual ingredient doses. Those are not trivial caveats for a product in the $49–69/month range.

The rating of 5.8 reflects genuine formulation quality that does not yet justify a purchase recommendation. A full Supplement Facts panel showing doses at or above the clinical benchmarks would move this to a conditional recommendation immediately. We will update this review if that information becomes available.

Skeptic Desk verdict: Cautious — 5.8/10. The ingredients are right. The doses are unknown. Do not commit to a six-bottle bundle of any supplement whose therapeutic dose you cannot verify from the label. Buy one bottle, request the full Supplement Facts panel from the vendor, and compare against the Mao et al., Mori et al., and Jorissen et al. thresholds before reordering.